Back to results
US 5,846,548 AGranted
Combined administration of mitogenic immumo stimulator and a thymomimetic
AssigneeBartos Patent Development & Holding Company, Limited
InventorStefan Bartos
Life of this patent
Estimating the term…
Abstract
A method of tumor therapy involves controlling the immune system by co-administration of a mitogenic immuno-stimulating substance and a thymomimetic substance.
Claims1
A method of inhibiting metastatic breast cancer, which comprises administering
- a) at least one mitogenically immuno-stimulating substance and
- b) at least one thymomimetic substance,
- wherein the mitogenically immuno-stimulating substance is mistletoe extract and the thymomimetic substance is thymus extract in amounts effective to inhibit metastatic breast cancer.
Dependencies are inferred from the claim text.